Breaking News, Collaborations & Alliances

Rakuten and LOTTE Sign Global Oncology Therapy Manufacturing Agreement

The two companies used the occasion of the J.P. Morgan Healthcare Conference to announce their partnership.

Author Image

By: Patrick Lavery

Content Marketing Editor

Rakuten Medical and LOTTE Biologics have signed a contract manufacturing agreement regarding oncology, the two companies announced at the J.P. Morgan Healthcare Conference in San Francisco. The pact strengthens Rakuten’s production capabilities for photoimmunotherapy based on its investigational Alluminox platform. This involves two main steps: drug administration, and targeted illumination using medical devices. According to Rakuten, the Alluminox platform combines pharmaceuticals, medica...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters